Another angiomiR involved in glioma blood vessel development is MiR-137, which inhibits proliferation and angiogenesis of human glioblastoma cells by targeting enhancer of zeste homolog 2 (EZH2), an enzyme participating in histone methylation and transcriptional repression [246]. This evidence concerns the gene EZH2 and central nervous system cancer.